Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy

OBJECTIVE: To investigate feasibility, safety, and tolerability of long‐term (48 weeks) add‐on treatment with triheptanoin (UX007), the triglyceride of heptanoate, in adults with drug‐resistant epilepsy. METHODS: This extension study was offered to adult participants with drug‐resistant epilepsy who...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Karin, Kaul, Neha, Germaine, Jack, Carrasco‐Pozo, Catalina, Kwan, Patrick, O’Brien, Terence J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278596/
https://www.ncbi.nlm.nih.gov/pubmed/32524048
http://dx.doi.org/10.1002/epi4.12391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278596/
https://www.ncbi.nlm.nih.gov/pubmed/32524048
http://dx.doi.org/10.1002/epi4.12391

Ejemplares similares